BAMCO INC /NY/ - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,566,000
-71.2%
78,200
-62.8%
0.01%
-75.0%
Q2 2018$5,429,000
+2.1%
210,184
-5.6%
0.02%0.0%
Q1 2018$5,319,000
+27.4%
222,566
+80.7%
0.02%
+26.3%
Q4 2017$4,175,000
+91.1%
123,200
+19.4%
0.02%
+90.0%
Q3 2017$2,185,000
+21.1%
103,2000.0%0.01%
+11.1%
Q2 2017$1,805,000
+45.4%
103,200
+45.5%
0.01%
+28.6%
Q1 2017$1,241,000
+88.3%
70,928
+81.9%
0.01%
+75.0%
Q4 2016$659,000
+176.9%
39,000
+169.0%
0.00%
+300.0%
Q3 2016$238,00014,5000.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders